|
|
Volumn 61, Issue 3, 2011, Pages 135-136
|
|
Denosumab an option for patients with bone metastasis from breast cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DENOSUMAB;
ZOLEDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
BONE DENSITY CONSERVATION AGENT;
IMIDAZOLE DERIVATIVE;
MONOCLONAL ANTIBODY;
OSTEOCLAST DIFFERENTIATION FACTOR;
ARTHRALGIA;
BONE METASTASIS;
BONE PAIN;
BREAST CANCER;
CANCER RADIOTHERAPY;
DISEASE COURSE;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
FEVER;
HUMAN;
HYPERCALCEMIA;
HYPOCALCEMIA;
JAW OSTEONECROSIS;
KIDNEY DYSFUNCTION;
ORTHOPEDIC SURGERY;
OVERALL SURVIVAL;
PATHOLOGIC FRACTURE;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
RISK REDUCTION;
SPINAL CORD COMPRESSION;
ARTICLE;
BONE TUMOR;
BREAST TUMOR;
DOUBLE BLIND PROCEDURE;
FEMALE;
METASTASIS;
OSTEOLYSIS;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL (TOPIC);
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
BONE DENSITY CONSERVATION AGENTS;
BONE NEOPLASMS;
BONE RESORPTION;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE III AS TOPIC;
DIPHOSPHONATES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
IMIDAZOLES;
RANK LIGAND;
TREATMENT OUTCOME;
|
|
EID: 79959774035
PISSN: 00079235
EISSN: 15424863
Source Type: Journal
DOI: 10.3322/caac.20116 Document Type: Review |
|
Times cited : (11)
|
|
References (0)
|
